Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DEHP Prop 65 listing

This article was originally published in The Rose Sheet

Executive Summary

California Office of Environmental Health Hazard Assessment lists di (2-ethylhexyl) phthalate as chemical known to the state to cause reproductive toxicity Oct. 24, agency announces. Listing based on "formal" identification by National Institute for Occupational Safety and Health and FDA that chemical causes developmental and male reproductive toxicity. OEHHA analyses of dose response data to establish a maximum allowable dose level for DEHP under Prop 65 will be designated a priority in future status report for safe harbor levels, agency reports. OEHHA announced intent to list DEHP in April in the California Regulatory Notice Register (1"The Rose Sheet" April 28, 2003, In Brief)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011614

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel